Non-Nucleoside Reverse Transcriptase Inhibitor | Rilpivirine | Phase III injectable (oral agent approved) | Janssen |
Integrase Inhibitor | Cabotegravir | Phase III injectable | ViiV |
Nucleoside/Nucleotide Reverse Transciptase Inhibitor (NRTI) | EFdA | Phase I | Merck |
Tenofovir alafenamide fumarate (TAF) | Preclinical implant (oral agent approved) | Gilead |
GS-9131 | Preclinical/Phase I | Gilead |
Capsid Inhibitor | GS-CA1 | Preclinical | Gilead |